Equels Thomas K 4
4 · AIM ImmunoTech Inc. · Filed Apr 23, 2025
Insider Transaction Report
Form 4
Equels Thomas K
CEO & President
Transactions
- Purchase
Common Stock
2025-04-11$0.03/sh+1,968,504$50,000→ 3,867,533 total
Footnotes (1)
- [F1]Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025.